FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134719891> ?p ?o ?g. }

• W2134719891 endingPage "624" @default.
• W2134719891 startingPage "623" @default.
• W2134719891 abstract "Peyronie's disease (PD) is a localized penile collagen disorder of the tunica albuginea associated with significant physical deformity and psychological impairment. Current understanding of pretreatment characteristics in patients with chronic PD is limited by small samples, varied quality of assessments, and the lack of a PD‐specific, validated measure of the psychosexual impact of PD.Reporting baseline demographic and disease characteristics of the large multinational cohort of subjects with chronic PD who participated in the collagenase clostridium histolyticum (CCH, an investigational intralesional injection and minimally invasive intervention) phase 3 clinical study program. Findings from well‐defined assessments, including the Peyronie's Disease Questionnaire (PDQ), the first validated PD‐specific patient‐reported measure of psychosexual impact, are reported.Subjects included men ≥18 years old with PD symptoms ≥12 months and penile deformity between 30° and 90°. Analysis data included demographics, disease history, and psychosexual impact.Penile deformity, disease symptoms, the International Index of Erectile Function, and the PDQ were assessed.Eight hundred thirty‐two subjects were enrolled from 64 sites across the United States and Australia. The mean age was 57.7 years; mean PD duration was 4.1 years. The majority of subjects had penile deformity ≤60° (77.3%); mean penile deformity was 50.5°. Subjects reported having intercourse a mean of 10.2 times in the previous 3 months, 70.8% reported difficulty in performing vaginal intercourse, and 80.4% reported less frequent vaginal intercourse. Approximately 71.5% of subjects with severe (>60°) and 58.1% of subjects with mild/moderate (≤60°) penile deformity were “very bothered” or “extremely bothered” upon last look at their erect penis (P = 0.0041), as measured by the PDQ.These data add to the body of knowledge regarding the clinical impact of chronic phase PD, including the PD-specific patient-reported psychosexual symptoms, using a large multinational chronic PD cohort in the CCH phase 3 clinical program. Gelbard M, Hellstrom WJG, McMahon CG, Levine LA, Smith T, Tursi J, Kaufman G, and Goldstein I. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease. J Sex Med 2013;10:2822–2831." @default.
• W2134719891 created "2016-06-24" @default.
• W2134719891 creator A5005702123 @default.
• W2134719891 creator A5044519122 @default.
• W2134719891 date "2013-04-01" @default.
• W2134719891 modified "2023-10-05" @default.
• W2134719891 title "Focal Therapy in the Treatment of Localised Prostate Cancer: Primum Non Nocere" @default.
• W2134719891 cites W2001652749 @default.
• W2134719891 cites W2045298462 @default.
• W2134719891 cites W2110569728 @default.
• W2134719891 cites W2121655616 @default.
• W2134719891 cites W2136220787 @default.
• W2134719891 cites W2140100183 @default.
• W2134719891 cites W3147941944 @default.
• W2134719891 doi "https://doi.org/10.1016/j.eururo.2012.12.027" @default.
• W2134719891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23290301" @default.
• W2134719891 hasPublicationYear "2013" @default.
• W2134719891 type Work @default.
• W2134719891 sameAs 2134719891 @default.
• W2134719891 citedByCount "3" @default.
• W2134719891 countsByYear W21347198912013 @default.
• W2134719891 countsByYear W21347198912014 @default.
• W2134719891 crossrefType "journal-article" @default.
• W2134719891 hasAuthorship W2134719891A5005702123 @default.
• W2134719891 hasAuthorship W2134719891A5044519122 @default.
• W2134719891 hasConcept C126322002 @default.
• W2134719891 hasConcept C141071460 @default.
• W2134719891 hasConcept C2779145901 @default.
• W2134719891 hasConcept C2779929075 @default.
• W2134719891 hasConcept C2779982284 @default.
• W2134719891 hasConcept C71924100 @default.
• W2134719891 hasConcept C72563966 @default.
• W2134719891 hasConceptScore W2134719891C126322002 @default.
• W2134719891 hasConceptScore W2134719891C141071460 @default.
• W2134719891 hasConceptScore W2134719891C2779145901 @default.
• W2134719891 hasConceptScore W2134719891C2779929075 @default.
• W2134719891 hasConceptScore W2134719891C2779982284 @default.
• W2134719891 hasConceptScore W2134719891C71924100 @default.
• W2134719891 hasConceptScore W2134719891C72563966 @default.
• W2134719891 hasIssue "4" @default.
• W2134719891 hasLocation W21347198911 @default.
• W2134719891 hasLocation W21347198912 @default.
• W2134719891 hasOpenAccess W2134719891 @default.
• W2134719891 hasPrimaryLocation W21347198911 @default.
• W2134719891 hasRelatedWork W1535771998 @default.
• W2134719891 hasRelatedWork W1963931039 @default.
• W2134719891 hasRelatedWork W1967416111 @default.
• W2134719891 hasRelatedWork W2049493942 @default.
• W2134719891 hasRelatedWork W2077318868 @default.
• W2134719891 hasRelatedWork W2089289585 @default.
• W2134719891 hasRelatedWork W2465219256 @default.
• W2134719891 hasRelatedWork W2474828202 @default.
• W2134719891 hasRelatedWork W2585377707 @default.
• W2134719891 hasRelatedWork W2089125259 @default.
• W2134719891 hasVolume "63" @default.
• W2134719891 isParatext "false" @default.
• W2134719891 isRetracted "false" @default.
• W2134719891 magId "2134719891" @default.
• W2134719891 workType "article" @default.